Fan Yuzhuo, Chu Huihui, Peng Zisu, Zhou Jingwei, Ma Jiahui, Lu Yuchang, Zhao Chenxu, Wang Yanyan, Deng Qiulin, Yu Jifeng, Li Yan, Wang Kai, Zhao Mingwei
Department of Ophthalmology, Peking University People's Hospital, Beijing, China; Eye Diseases and Optometry Institute, Beijing, China; Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China; College of Optometry, Peking University Health Science Center, Beijing, China.
Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
J Optom. 2025 Jan-Mar;18(1):100533. doi: 10.1016/j.optom.2024.100533. Epub 2025 Jan 11.
To investigate the 12-month effectiveness of Diverse Segmented Defocus Optics (DSDO) and Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in a real-world clinical population in myopic and pre-myopic Chinese children.
About 364 subjects prescribed DSDO or DIMS were enrolled. Axial length (AL) and cycloplegic spherical equivalent refraction (SER) changes over 12 months were measured. The subjects were further divided into age sub-group (6-9; 10-14) and SER sub-group (+0.75D≤SER<-0.50D; -0.50D≤SER<-2.00D; -2.00D≤SER<-4.00D; SER≤-4.0D). Contrast sensitivity and visual experience were also reported. The rate of myopia progression was compared with historical single-vision spectacles (SVS) lenses data to evaluate the effectiveness of the regime.
317 subjects were analyzed. At 12-month, AL changes in the DSDO and DIMS group were 0.16±0.16 mm and 0.21±0.22 mm, respectively (P = 0.0202). DSDO spectacle lenses had better control effect in +0.75D≤SER<-0.50D and SER≤-2.0D sub-groups. The proportion of participants had no greater than 0.20 mm AL elongation was 65.00% and 55.41% of in DSDO and DIMS group separately. Myopia control effect in DSDO group was 47%-69% and 33%-62% in DIMS group compared to historical SVS lenses.
Both DSDO and DIMS spectacle lenses retarded AL elongation. DSDO showed more stable myopia control effect comparing to DIMS, especially in groups of SER≤-2.0D sub-groups and older patients. DSDO showed initial potential myopia prevention effect in pre-myopic children compared with historical SVS lenses data. However, the small sample and no control group in pre-myopes of this study are key limitations. Further research is needed to confirm and understand DSDO's role for pre-myopic children.
研究多样分段离焦光学镜片(DSDO)和多焦点离焦镜片(DIMS)对中国近视及近视前期儿童在现实临床环境中的12个月有效性。
招募约364名配镜处方为DSDO或DIMS的受试者。测量12个月内的眼轴长度(AL)和睫状肌麻痹等效球镜度(SER)变化。受试者进一步分为年龄亚组(6 - 9岁;10 - 14岁)和SER亚组(+0.75D≤SER<-0.50D;-0.50D≤SER<-2.00D;-2.00D≤SER<-4.00D;SER≤-4.0D)。还报告了对比敏感度和视觉体验。将近视进展率与历史单焦点眼镜(SVS)镜片数据进行比较,以评估该方案的有效性。
分析了其中317名受试者。12个月时,DSDO组和DIMS组的AL变化分别为0.16±0.16毫米和0.21±0.22毫米(P = 0.0202)。DSDO眼镜片在+0.75D≤SER<-0.50D和SER≤-2.0D亚组中具有更好的控制效果。AL伸长不超过0.20毫米的参与者比例在DSDO组和DIMS组中分别为65.00%和55.41%。与历史SVS镜片相比,DSDO组的近视控制效果为47% - 69%,DIMS组为33% - 62%。
DSDO和DIMS眼镜片均能延缓AL伸长。与DIMS相比,DSDO显示出更稳定的近视控制效果,尤其是在SER≤-2.0D亚组和年龄较大的患者中。与历史SVS镜片数据相比,DSDO在近视前期儿童中显示出初步的潜在近视预防效果。然而,本研究中近视前期儿童样本量小且无对照组是关键局限性。需要进一步研究以确认和了解DSDO对近视前期儿童的作用。